These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 22315020

  • 1. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
    Qian F, Wang J, Hartley R, Tao J, Haddadin R, Mathias N, Hussain M.
    Pharm Res; 2012 Oct; 29(10):2765-76. PubMed ID: 22315020
    [Abstract] [Full Text] [Related]

  • 2. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F.
    Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
    [Abstract] [Full Text] [Related]

  • 3. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L, Tajber L.
    Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
    [Abstract] [Full Text] [Related]

  • 4. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y, Liu C, Chen Z, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F.
    Mol Pharm; 2015 Feb 02; 12(2):576-89. PubMed ID: 25535667
    [Abstract] [Full Text] [Related]

  • 5. Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions.
    Liu L, Chen L, Müllers W, Serno P, Qian F.
    Mol Pharm; 2022 Aug 01; 19(8):2888-2899. PubMed ID: 35759395
    [Abstract] [Full Text] [Related]

  • 6. Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study.
    Sakurai A, Sakai T, Sako K, Maitani Y.
    Chem Pharm Bull (Tokyo); 2012 Aug 01; 60(4):459-64. PubMed ID: 22466729
    [Abstract] [Full Text] [Related]

  • 7. Part II: bioavailability in beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion.
    Zheng X, Yang R, Zhang Y, Wang Z, Tang X, Zheng L.
    Drug Dev Ind Pharm; 2007 Jul 01; 33(7):783-9. PubMed ID: 17654027
    [Abstract] [Full Text] [Related]

  • 8. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA.
    Wlodarski K, Sawicki W, Kozyra A, Tajber L.
    Eur J Pharm Biopharm; 2015 Oct 01; 96():237-46. PubMed ID: 26247119
    [Abstract] [Full Text] [Related]

  • 9. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S, de Armas HN, Roberts CJ, Van den Mooter G.
    J Pharm Sci; 2008 Jun 01; 97(6):2110-20. PubMed ID: 17847067
    [Abstract] [Full Text] [Related]

  • 10. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance.
    Chen H, Pui Y, Liu C, Chen Z, Su CC, Hageman M, Hussain M, Haskell R, Stefanski K, Foster K, Gudmundsson O, Qian F.
    J Pharm Sci; 2018 Jan 01; 107(1):317-326. PubMed ID: 29107047
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S, Rudraraju VS.
    AAPS PharmSciTech; 2015 Oct 01; 16(5):1079-90. PubMed ID: 25672820
    [Abstract] [Full Text] [Related]

  • 14. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H, Handa T, Alonzo DE, Taylor LS.
    Eur J Pharm Biopharm; 2008 Oct 01; 70(2):493-9. PubMed ID: 18577451
    [Abstract] [Full Text] [Related]

  • 15. Effect of polymer type and drug dose on the in vitro and in vivo behavior of amorphous solid dispersions.
    Knopp MM, Chourak N, Khan F, Wendelboe J, Langguth P, Rades T, Holm R.
    Eur J Pharm Biopharm; 2016 Aug 01; 105():106-14. PubMed ID: 27212472
    [Abstract] [Full Text] [Related]

  • 16. Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.
    Knopp MM, Nguyen JH, Mu H, Langguth P, Rades T, Holm R.
    AAPS J; 2016 Mar 01; 18(2):416-23. PubMed ID: 26769250
    [Abstract] [Full Text] [Related]

  • 17. Using Supercritical Fluid Technology (SFT) in Preparation of Tacrolimus Solid Dispersions.
    Obaidat RM, Tashtoush BM, Awad AA, Al Bustami RT.
    AAPS PharmSciTech; 2017 Feb 01; 18(2):481-493. PubMed ID: 27116202
    [Abstract] [Full Text] [Related]

  • 18. Pairwise polymer blends for oral drug delivery.
    Marks JA, Wegiel LA, Taylor LS, Edgar KJ.
    J Pharm Sci; 2014 Sep 01; 103(9):2871-2883. PubMed ID: 24823790
    [Abstract] [Full Text] [Related]

  • 19. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
    Danda LJA, Batista LM, Melo VCS, Soares Sobrinho JL, Soares MFR.
    Eur J Pharm Sci; 2019 May 15; 133():79-85. PubMed ID: 30890364
    [Abstract] [Full Text] [Related]

  • 20. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ, Kestur US, Hussain MA, Taylor LS.
    Mol Pharm; 2016 Jan 04; 13(1):223-31. PubMed ID: 26618718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.